Owlstone Medical announces digital Breath Biopsy Conference 2021

Join leading researchers online to explore the latest advances and common challenges in the field of breath biopsy

5 Oct 2021
Blake Forman
Content Creator

Industry news

Owlstone Medical has announced the next Breath Biopsy Conference will take place online, October 12-13, 2021. The conference is free to register and seeks to facilitate progress in the breath research field by bringing together leading researchers and research organizations to share the latest advances and to discuss common challenges.

Breath research seeks to use non-invasive breath testing approaches, such as breath biopsy, to detect, diagnose and find the best treatment strategies for a multitude of different conditions. These approaches provide readouts of a patient’s metabolic state, so are more directly linked to current disease progression than is possible through genetic testing. As such, this field has many potential applications in early detection and precision medicine.

During this two-day event, the key areas of expertise in and around the breath research field will be explored in talks, poster sessions, and discussions. This year's major themes are focused on the importance and advantages of early detection of disease, the value and benefits of precision medicine, the use of traceable compounds (such as d5-ethanol, C13-labeled compounds, and limonene) in breath studies, and sampling and analysis.

Secure your free place at Breath Biopsy Conference 2021 here>>

Breath Biopsy® Services

Owlstone Medical

Combining high resolution accurate mass mass spectrometry and world-leading breath analysis expertise to offer complete breath biomarker discovery and validation solutions. Breath Biopsy Services provide versatile Breath Biopsy sample analysis and reporting driven by GC-Orbitrap technology and supported by a rigorous quality assurance process ensuring reliable, high sensitivity VOC biomarker detection.

(0)

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.Cardiovascular DiseaseCardiovascular disease refers to a group of disorders of the heart and blood vessels, including heart attacks, strokes, and high blood pressure. Early diagnosis and effective treatment are essential for improving patient outcomes. Explore cardiovascular disease research and diagnostic tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Precision MedicinePrecision medicine refers to the idea of customized healthcare, where medical decisions and treatments are tailored to the individual patient. Molecular diagnostics, companion diagnostics and Next Generation Sequencing (NGS) play a pivotal role in this approach.